calendar
8,729 catalysts · 3,126 8k filing · 1,702 grant · 1,000 device adverse event · 795 approval · 621 device 510k · 583 earnings
8,729 catalysts · 3,126 8k filing · 1,702 grant · 1,000 device adverse event · 795 approval · 621 device 510k · 583 earnings
Supplement type: 30-Day Notice. Product code: QON. Advisory committee: GU. Decision: OK30
Supplement type: 30-Day Notice. Product code: MHY. Advisory committee: NE. Decision: OK30
Supplement type: 30-Day Notice. Product code: QPT. Advisory committee: GU. Decision: OK30
Supplement type: 30-Day Notice. Product code: LWP. Advisory committee: CV. Decision: OK30
Supplement type: 30-Day Notice. Product code: NIK. Advisory committee: CV. Decision: OK30
Supplement type: Special (Immediate Track). Product code: QVG. Advisory committee: CV. Decision: APPR
Supplement type: Normal 180 Day Track No User Fee. Product code: QAN. Advisory committee: CV. Decision: APPR
Supplement type: 30-Day Notice. Product code: NPT. Advisory committee: CV. Decision: OK30
Supplement type: 30-Day Notice. Product code: NPW. Advisory committee: CV. Decision: OK30
Supplement type: 30-Day Notice. Product code: LGW. Advisory committee: NE. Decision: OK30
Supplement type: 30-Day Notice. Product code: LWS. Advisory committee: CV. Decision: OK30
Supplement type: 30-Day Notice. Product code: MAE. Advisory committee: CV. Decision: OK30
Supplement type: 30-Day Notice. Product code: LKK. Advisory committee: HO. Decision: OK30
Supplement type: 135 Review Track For 30-Day Notice. Product code: NPT. Advisory committee: CV. Decision: APPR
Supplement type: Normal 180 Day Track No User Fee. Product code: QZI. Advisory committee: CV. Decision: APPR
Supplement type: 135 Review Track For 30-Day Notice. Product code: LWR. Advisory committee: CV. Decision: APPR
Supplement type: 30-Day Notice. Product code: MTG. Advisory committee: IM. Decision: OK30
Supplement type: 135 Review Track For 30-Day Notice. Product code: NPV. Advisory committee: CV. Decision: APPR
Supplement type: 30-Day Notice. Product code: MAQ. Advisory committee: MI. Decision: OK30
Product code: SGK. Advisory committee: OR. Decision: APPR
Supplement type: Special (Immediate Track). Product code: NJL. Advisory committee: OR. Decision: APPR
Supplement type: 30-Day Notice. Product code: NVZ. Advisory committee: CV. Decision: OK30
Supplement type: 135 Review Track For 30-Day Notice. Product code: DYE. Advisory committee: CV. Decision: APPR
Flexible Cryoprobe (OD 1.1mm, L1.15mm) w/ oversheath (OD2.6mm, L817mm) REF: 20402-401 STERILEEO. For surgical use — Reason: Probes may rupture/burst during activation — Status: Ongoing
Flexible Cryoprobe (OD 2.4mm, L1.15mm) REF: 20402-411. For surgical use — Reason: Probes may rupture/burst during activation — Status: Ongoing
Olympus Endoscope Suction Valve - MAJ-1443. Model Number: MAJ-1443. — Reason: The MAJ-1443 and MAJ-1444 are no longer reprocessing compatible with the OER-Pro and OER-Elite automated endoscope reprocessors. — Status: Ongoing
Olympus Endoscope Reprocessor OER-Pro. Model Number: N3058140. — Reason: The MAJ-1443 and MAJ-1444 are no longer reprocessing compatible with the OER-Pro and OER-Elite automated endoscope reprocessors. — Status: Ongoing
Olympus Endoscope Reprocessor OER-Elite. Model Number: N5789340. — Reason: The MAJ-1443 and MAJ-1444 are no longer reprocessing compatible with the OER-Pro and OER-Elite automated endoscope reprocessors. — Status: Ongoing
Olympus Endoscope Air/Water Valve - MAJ-1444. Model Number: MAJ-1444. — Reason: The MAJ-1443 and MAJ-1444 are no longer reprocessing compatible with the OER-Pro and OER-Elite automated endoscope reprocessors. — Status: Ongoing
Flexible Cryoprobe (OD 1.7mm, L1.15mm) REF: 20402-410. For surgical use — Reason: Probes may rupture/burst during activation — Status: Ongoing
TW grant. $372,306. PI: Farrah Jasmine Mateen
GM grant. $191,972. PI: June Bryan de la Pena
AI grant. $407,326. PI: STEPHEN C JAMESON
GM grant. $423,734. PI: Nir Yakoby
Sponsor: ZYDUS LIFESCIENCES. Form: GEL. Route: TOPICAL
Sponsor: AVYXA HOLDINGS. Form: SOLUTION. Route: INTRAVENOUS
Sponsor: HQ SPCLT PHARMA. Form: POWDER. Route: INTRAVENOUS
Sponsor: HARMONY. Form: TABLET. Route: ORAL
Sponsor: UNICHEM. Form: TABLET. Route: ORAL
Sponsor: UNICHEM. Form: TABLET. Route: ORAL
Sponsor: WA UNIV SCH MED. Form: INJECTABLE. Route: INTRAVENOUS
Sponsor: JANSSEN BIOTECH. Form: VIAL. Route: SINGLE-USE
Sponsor: BAYER HLTHCARE. Form: SOLUTION. Route: INTRAVENOUS
Sponsor: AOP HLTH US. Form: POWDER. Route: INTRAVENOUS
Sponsor: BAYER HLTHCARE. Form: SOLUTION. Route: INTRAVENOUS
Sponsor: MACLEODS PHARMS LTD. Form: TABLET. Route: ORAL
Product code: DXQ. Advisory committee: Cardiovascular. Type: Traditional
Product code: OLX. Advisory committee: Neurology. Type: Special
Product code: HGX. Advisory committee: Obstetrics/Gynecology. Type: Traditional
Product code: LIT. Advisory committee: Cardiovascular. Type: Traditional